Dr Steven Yakubov (OhioHealth Riverside Methodist Hospital, Columbus, OH, US) discusses 1-year outcomes of TAVR vs SAVR in patients at intermediate surgical risk - a propensity-match analysis from the SURTAVI trial.
Filmed on site at CRT 2019 by Radcliffe Cardiology
1. Why did you conduct this analysis?
2. How was data collected and analysed?
3. What were your findings?
4. How does this complement existing data and what are the implications for practice?